Salvesen & Thams completed the acquisition of a 45% minority stake in Vitux from Investinor.

Synopsis

Salvesen & Thams, an investment company, completed the acquisition of a 45% minority stake in Vitux, a manufacturer of dietary supplements and nutraceuticals, from Investinor, an investment company. Financial terms were not disclosed.

Principals

target

Vitux Group

bidder

Salvesen & Thams

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (1)

klaus neumann

CEO at VITUX GROUP

Manager

target

Deal

n/a

Total Value

Bidder Team (1)

per olav monseth

General Manager at SALVESEN & THAMS

Manager

bidder

Deals

n/a

Total Value

Vendor Team (1)

ann-tove kongsnes

Investment Director at INVESTINOR

Investor

vendor

Deal

n/a

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy